# Pharmacokinetic Interaction and Safety/Tolerability Between NVP-1805-R1 and NVP-1805-R2

> **NCT03802526** · PHASE1 · COMPLETED · sponsor: **NVP Healthcare** · enrollment: 37 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** NVP-1805-R1
- **DRUG:** NVP-1805-R2
- **DRUG:** NVP-1805-R1 and NVP-1805-R2

## Key facts

- **NCT ID:** NCT03802526
- **Lead sponsor:** NVP Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-03
- **Primary completion:** 2019-07-04
- **Final completion:** 2019-09-27
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2019-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03802526

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03802526, "Pharmacokinetic Interaction and Safety/Tolerability Between NVP-1805-R1 and NVP-1805-R2". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03802526. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*